Mark Rosen

Locally Advanced Breast Cancer: MR Imaging for Prediction of Response to Neoadjuvant Chemotherapy—Results from ACRIN 6657/I-SPY TRIAL

Nola M. Hylton, Jeffrey D. Blume, Wanda K. Bernreuter et al. · Radiology · 2012 · 489 citations

Medicine, Oncology, Radiology +17

Three-dimensional in vivo fluorescence diffuse optical tomography of breast cancer in humans

Alper Corlu, Regine Choe, Turgut Durduran et al. · Optics Express · 2007 · 390 citations · Full text

Medicine, Biomedical Engineering, Oncology +17

CDK 4/6 Inhibitor Palbociclib (PD0332991) in Rb+ Advanced Breast Cancer: Phase II Activity, Safety, and Predictive Biomarker Assessment

Angela DeMichele, Amy S. Clark, Kay See Tan et al. · Clinical Cancer Research · 2014 · 348 citations

Medicine, Oncology, Pharmacology +17

Diffuse optical tomography of breast cancer during neoadjuvant chemotherapy: A case study with comparison to MRI

Regine Choe, Alper Corlu, Kijoon Lee et al. · Medical Physics · 2005 · 298 citations

Medicine, Oncology, Radiology +17

Phase I Trial of the Antivascular Agent Combretastatin A4 Phosphate on a 5-Day Schedule to Patients With Cancer: Magnetic Resonance Imaging Evidence for Altered Tumor Blood Flow

James Stevenson, Mark Rosen, Weijing Sun et al. · Journal of Clinical Oncology · 2003 · 293 citations

Medicine, Oncology, Pharmacology +17